RIVAROXABAN

Clinical Indication

Treatment and secondary prevention of DVT and PE

Comments

In line with  NICE TA 261  or  NICE TA 287

Date of classification

September 2012

Review date

October 2016

Amber SIMPLE

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.